SCHEMBL958199

SCHEMBL958199

COc1ccc(CCNc2nccc(-c3cccc(C(=O)NCCCN4CCCC4)c3)n2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD2 Q9NRG4 5/20 0.51
INSR P06213 2/20 0.49
F10 P00742 1/20 0.48
CCNT1 O60563 1/20 0.48
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
CDK9 P50750 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPK1 P28482 2/20 0.48
IKBKB O14920 1/20 0.48
ABL1 P00519 1/20 0.48
MET P08581 1/20 0.48
SRC P12931 1/20 0.48
AXL P30530 1/20 0.48
GSK3B P49841 1/20 0.48
TYRO3 Q06418 1/20 0.48
MERTK Q12866 1/20 0.48
PIM2 Q9P1W9 1/20 0.48
ABCB1 P08183 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12918993 0.95 ABCB1 (0.52) INSRF10CCNT1CCNA2CDK2
SCHEMBL12919003 0.89 ABCB1 (0.53) F10ABL1ABCB1KMT2A
SCHEMBL12919045 0.89 INSR (0.51) SMYD2INSRF10ABL1ABCB1
SCHEMBL3400297 0.87 CCNT1 (0.52) CCNT1CCNA2CDK2CDK9MAPK1
SCHEMBL12918930 0.87 ABL1 (0.55) CCNT1CCNA2CDK2CDK9CYP2C9
Hydrochloric Acid SCHEMBL962334 0.86 ABL1 (0.54) CCNT1CCNA2CDK2CDK9CYP2C9
SCHEMBL958575 0.86 FYN (0.52) INSRCCNT1CCNA2CDK2CDK9
SCHEMBL12918991 0.86 SMYD2 (0.54) SMYD2CCNT1CCNA2CDK2CDK9
SCHEMBL12918981 0.85 SMYD2 (0.56) SMYD2CYP2C9ABCB1
SCHEMBL3400324 0.85 MAPT (0.49) INSRCCNT1CCNA2CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 SMYD2 2582/4885INSR 444/4885F10 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.